Financhill
Back

CytoMed Therapeutics Quote, Financials, Valuation and Earnings

CytoMed Therapeutics Price Quote

$1.95
-0.22 (-8.02%)
(Updated: November 16, 2024 at 5:19 AM ET)

CytoMed Therapeutics Key Stats

Sell
50
CytoMed Therapeutics (GDTC) is a Sell

Day range:
$1.83 - $2.52
52-week range:
$1.20 - $5.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.35%

Volume:
10.8K
Avg. volume:
19.4K
1-year change:
-45.78%
Market cap:
$25.1M
Revenue:
$0
EPS:
$-0.19

How Much Does CytoMed Therapeutics Make?

Data Unavailable

Is CytoMed Therapeutics Growing As A Company?

Data Unavailable

CytoMed Therapeutics Stock Price Performance

What Is CytoMed Therapeutics 52-Week High & Low?

CytoMed Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CytoMed Therapeutics?

Is CytoMed Therapeutics Cash Flow Positive?

  • What Is GDTC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.9M
  • What Is CytoMed Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$22.2K
  • What Is CytoMed Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $554K

CytoMed Therapeutics Return On Invested Capital

Data Unavailable

CytoMed Therapeutics Earnings Date & Stock Price

CytoMed Therapeutics Competitors

CytoMed Therapeutics Dividend Yield

CytoMed Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.00
Upside from Last Price: 129.96%

Major Shareholders

  • How many GDTC shares are owned by institutional investors?
    4.9K GDTC shares are owned by institutional investors
  • How many GDTC shares are owned by insiders?
    681.8K GDTC shares are owned by insiders